Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$22.3 - $36.29 $176,170 - $286,691
7,900 Added 26.33%
37,900 $869,000
Q2 2024

Aug 14, 2024

SELL
$16.07 - $31.84 $17,677 - $35,024
-1,100 Reduced 3.54%
30,000 $866,000
Q1 2024

May 15, 2024

BUY
$17.13 - $26.91 $89,076 - $139,932
5,200 Added 20.08%
31,100 $641,000
Q4 2023

Feb 14, 2024

BUY
$21.58 - $29.5 $254,643 - $348,100
11,800 Added 83.69%
25,900 $700,000
Q3 2023

Nov 15, 2023

BUY
$25.8 - $39.97 $363,780 - $563,577
14,100 New
14,100 $417,000

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.23B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.